Trial Profile
Phase II Study of an All-Oral Combination of Capecitabine (X) and Cyclophosphamide (C) in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 04 Feb 2008 New trial record.